Women had been “advised to avoid becoming pregnant.”
- The U.S. Centers for Disease Control and Prevention (CDC) held a virtual meeting in October 2020 to discuss the safety data behind Bavarian Nordic’s “Jynneos” smallpox and monkeypox vaccine, the jab currently being promoted in response to the reported monkeypox outbreak.
- A little over an hour into the meeting, the CDC’s Dr. Brett Petersen presents a slide explaining how four female study participants became pregnant after receiving the Jynneos vaccine despite being “advised to avoid becoming pregnant.”
- Dr. Petersen describes how one out of these four pregnant women suffered a “spontaneous abortion”: “These pregnancies were followed up to delivery, and three participants delivered healthy babies, while one experienced a spontaneous abortion at an estimated 37 weeks of gestation based on her last menstrual period,” says Petersen.
WATCH THE CDC VIRTUAL MEETING SEGMENT:
WHAT THE SLIDE SAYS:
- The CDC’s slide on the Jynneos monkeypox vaccine’s effect on human pregnancy is titled “Preliminary Safety Analysis – Cohort 1 (Liquid Frozen) Pregnancies.”
- The slide goes on to say, “All female participants were advised to avoid becoming pregnant for one month (28 days) after each study vaccine administration. However, the occurrence of pregnancies among study participants was not unexpected among this population with relatively high fecundity.”
- “3 participants delivered healthy babies and one participant experienced a spontaneous abortion at an estimated 37 weeks gestation based on her last menstrual period.”
- “Estimated annual infant death rate in DRC is 65 infant deaths per 1,000 live births,” the slide concludes.
- Biotech company Bavarian Noric manufactures its “Jynneos” vaccine, one of two monkeypox vaccines licensed in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC).
- American Faith recently reported how the package insert for the Jynneos vaccine states that heart problems of “special interest” occur in 1 in 75 vaccine recipients who have not already been vaccinated against smallpox and in 1 in 48 vaccine recipients who have already been vaccinated against smallpox. The Jynneos vaccine contains tromethamine, a drug used to treat heart attacks.